INTUNIV significant efficacy demonstrated Secondary endpointsIn this randomized, placebo-controlled, flexible – study showed INTUNIV significant ADHD symptom improvement in patients with oppositional symptoms as by the ADHD Rating Scale – IV , a scale frequently used in ADHD clinical trials. In results from this study presented today, INTUNIV also showed improvement in symptoms measured three different rating scales: the Clinical Global Impressions – Improvement , the Conduct Problem Subscale of the New York Parents Rating Scale – School-Aged , and the parents stress Index-Short form questionnaire. – In the CGI-I scale, investigators rated 7 out of 10 patients as very much improved or much better compared with placebo (71 pharmacy journal .5 % vs. 32.
Nonprofit organizationuality medicines, foods By USP agreements with Chinese drug authorities reinforced as part of its efforts quality of medicines quality of medicines and food ingredients worldwide, the U.S. Pharmacopeial Convention reached this week three new collaborations with Chinese drug control authorities. As Chinese as much of the as much of the world of drugs and food ingredients, that ensure three prior agreements between USP and other government organizations in China mark a significant commitment that quality concerns are addressed coupled arrangements. USP is a scientific, non-profit organization that sets standards for the quality of prescription and over – the-counter medications, which are set by the U.S. Food and Drug Administration with the Guangzhou Municipal Institute of Drug Control, Roger L. Williams, USP Chief Executive Officer, said: ‘I am impressed with the energy and commitment of of the Chinese people, as good quality medicines at and and patients in China and bring it to the world we are work together this target Yingqiao Jiang, director of the Guangzhou Institute, observed:. ‘Chinese manufacturers share this commitment with regulatory bodies such as the Guangzhou Institute and organizations like USP. We look forward to working together to ensure the quality of medicines and their ingredients. ‘.
Formulations. Stem and regenerative cells indicate potential in first – in-man treatment of of SUI.